DOUBLE VACCINATED? HERE’S YOUR CHANCE TO AVAIL 20% OFF ON DOMESTIC BOOKINGS!

Mumbai, December 22, 2021: GO FIRST (formerly known as GoAir) today announced the introduction of a special 20 per cent discount on domestic flights for passengers who have received the second dose of the Covid vaccine.

The airline aims to encourage more people to get fully vaccinated in the fight against the COVID-19 virus.

This offer can be availed on booking through GO FIRST website and Mobile App, by entering the promo code GOVACCI. This discount is applicable for travel dates beyond 15 days from the date of booking.

Mr. Kaushik Khona, Chief Executive Officer, GO FIRST, said:The past two years have been extremely difficult due to COVID-19, which has redefined the meaning of normal. We at GO FIRST are committed to ensuring the safety of all our stakeholders. We began by supporting the vaccination of all our employees and now we encourage more people to get inoculated. We understand the need for vaccination, especially in wake of the new variant and will continue to support India’s fight against COVID.”

GO FIRST was among one of the first corporates in India to initiate a vaccination drive for its employees. This offer further reinforces GO FIRST’s commitment to fighting COVID.

 

About GO FIRST:

Founded as GoAir, GO FIRST, which was recently rebranded from GO AIR, is the aviation foray of 285-year-old Wadia Group that comprises leading brands including 150-year-old Bombay Burmah, 140-year-old Bombay Dyeing, 102-year-old Britannia Ltd., 67-year-old National Peroxide Limited, a nine-year-old Bombay Realty.

Media contacts:

Go First

Ratnadeep N Sur

General Manager – PR & Corporate Communications

Cell 1: +919967720143

Cell 2: +919930097185

Email: ratnadeep.sur@flygofirst.com

Website: www.flygofirst.com

 

Disclaimer: Go Airlines (India) Limited is proposing, subject to receipt of requisite approvals, market conditions and other considerations, an initial public offering of its equity shares (the “Equity Shares”) and has filed a draft red herring prospectus (the “DRHP”) with the Securities and Exchange Board of India (“SEBI”). The DRHP is available on the website of SEBI at www.sebi.gov.in and the respective websites of the Global Coordinators and Book Running Lead Managers at www.icicisecurities.comwww.online.citibank.co.in/rhtm/citigroupglobalscreen1.htmwww.morganstanley.com, respectively. Any potential investor should note that investment in equity shares involves a high degree of risk. For details, potential investors should refer to the DRHP, including the section titled “Risk Factors”. Potential investors should not rely on the DRHP for any investment decision. These materials are not for publication or distribution, directly or indirectly, in or into the United States (including its territories and possessions, any state of the United States and the District of Columbia). These materials are not an offer of securities for sale into the United States, Canada or Japan. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States, except pursuant to an applicable exemption from registration. No public offering of securities is being made in the United States.